The U.S. Food and Drug Administration released the agency’s first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a ...

Learning action models is pivotal to the advancement of Artificial Intelligence (AI) planning, offering a framework for autonomously synthesising reliable and optimised strategies for complex ...

On January 12, the U.S. Food and Drug Administration (FDA) released its Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. The action plan ...

A concern with many who are in the business of offering workshops and trainings is to demonstrate that they have an impact on business results. The challenge is to show a direct correlation between ...

You’ve consented participants, and now they are coming back for research visits. You have some changes to the project that requires you to re-consent them. Are you prepared to explain the changes well ...

On January 12, 2021, the US Food and Drug Administration (FDA) released its Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. The Action Plan ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

SILVER SPRING, Md., Jan. 12, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical ...